The Discounted Cash Flow (DCF) valuation of Sinil Pharmaceutical Co Ltd (012790.KQ) is 15,330.36 KRW. With the latest stock price at 6,390.00 KRW, the upside of Sinil Pharmaceutical Co Ltd based on DCF is 139.9%.
Based on the latest price of 6,390.00 KRW and our DCF valuation, Sinil Pharmaceutical Co Ltd (012790.KQ) is a buy. buying 012790.KQ stocks now will result in a potential gain of 139.9%.
| Range | Selected | |
| WACC / Discount Rate | 6.8% - 8.7% | 7.8% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 13,082.94 - 18,670.57 | 15,330.36 |
| Upside | 104.7% - 192.2% | 139.9% |